carvedilol and Neurodegenerative Diseases studies

carvedilol and Neurodegenerative Diseases

Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Research Excerpts

Excerpt	Relevance	Reference
" The dose-response relationship between the administered beta blockers and respiratory rates was examined using multivariable regression models."	1.91	Impact of beta blockers on resting respiratory rate in older adults: A cross-sectional study. ( Nagamine, T; Takayama, A; Yoshioka, T, 2023)
"Carvedilol is an adrenergic receptor antagonist."	1.91	Remyelinating activities of Carvedilol or alpha lipoic acid in the Cuprizone-Induced rat model of demyelination. ( Ahmed, KA; Ibrahim Fouad, G, 2023)

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	2 (50.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (25.00)

29.6817

2010's

1 (25.00)

24.3611

2020's

2 (50.00)

2.80

Authors

Authors	Studies
Takayama, A	1
Yoshioka, T	1
Nagamine, T	1
Ibrahim Fouad, G	1
Ahmed, KA	1
Saeidnia, S	1
Abdollahi, M	1
Mason, RP	1
Cockcroft, JR	1

Studies

Takayama, A

Yoshioka, T

Nagamine, T

Ibrahim Fouad, G

Ahmed, KA

Saeidnia, S

Abdollahi, M

Mason, RP

Cockcroft, JR

Reviews

2 reviews available for carvedilol and Neurodegenerative Diseases

Article	Year
Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicology and applied pharmacology, 2013, Dec-15, Volume: 273, Issue:3 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; B	2013
Targeting nitric oxide with drug therapy. Journal of clinical hypertension (Greenwich, Conn.), 2006, Volume: 8, Issue:12 Suppl 4 Topics: Adrenergic alpha-Antagonists; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzopyrans	2006

Article

Year

Toxicological and pharmacological concerns on oxidative stress and related diseases.

Toxicology and applied pharmacology, 2013, Dec-15, Volume: 273, Issue:3

Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; B

2013

Targeting nitric oxide with drug therapy.

Journal of clinical hypertension (Greenwich, Conn.), 2006, Volume: 8, Issue:12 Suppl 4

Topics: Adrenergic alpha-Antagonists; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzopyrans

2006

Other Studies

2 other studies available for carvedilol and Neurodegenerative Diseases

Article	Year
Impact of beta blockers on resting respiratory rate in older adults: A cross-sectional study. Pulmonary pharmacology & therapeutics, 2023, Volume: 78 Topics: Adrenergic beta-Antagonists; Aged; Carvedilol; Cross-Sectional Studies; Heart Failure; Humans; Neuro	2023
Remyelinating activities of Carvedilol or alpha lipoic acid in the Cuprizone-Induced rat model of demyelination. International immunopharmacology, 2023, Volume: 118 Topics: Animals; Carvedilol; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Mice; Mice, Inbred C	2023

Article

Year

Impact of beta blockers on resting respiratory rate in older adults: A cross-sectional study.

Pulmonary pharmacology & therapeutics, 2023, Volume: 78

Topics: Adrenergic beta-Antagonists; Aged; Carvedilol; Cross-Sectional Studies; Heart Failure; Humans; Neuro

2023

Remyelinating activities of Carvedilol or alpha lipoic acid in the Cuprizone-Induced rat model of demyelination.

International immunopharmacology, 2023, Volume: 118

Topics: Animals; Carvedilol; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Mice; Mice, Inbred C

2023